Placenta Previa Clinical Trial
Official title:
The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta: a Prospective Study
Placenta previa and placenta accrete carry significant maternal and fetal morbidity and mortality. Several techniques have been described in the literature for controlling massive bleeding associated with placenta previa cesarean sections. The aim of this study is to evaluate the efficacy and safety of the use of the cervix as a natural tamponade in controlling postpartum hemorrhage caused by placenta previa and placenta previa accreta.
Status | Recruiting |
Enrollment | 0 |
Est. completion date | May 2018 |
Est. primary completion date | May 2017 |
Accepts healthy volunteers | |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: 1. All participating women had one or more previous cesarean deliveries. 2. were diagnosed with placenta previa and/ or placenta previa accreta by ultrasound. When the ultrasound result was not conclusive for placenta accreta, MRI was performed. 3. All participating women desired to preserve their fertility 4. Patients with focal (partial) placenta previa accreta/ placenta previa. Exclusion Criteria: 1. placenta percreta. 2. diffuse placenta accreta or increta. 3. uncontrollable postpartum hemorrhage. |
Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Egypt | Department of Obstetrics and Gynaecology, Minia University Hospital | Minia |
Lead Sponsor | Collaborator |
---|---|
Minia University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Successful control of postpartum haemorrhage (PPH) | Control of PPH and vaginal bleeding after employing the technique | Intra-operative and up to 24 hours postpartum | |
Primary | Number of cases undergoing hysterectomy to control PPH | Failure of the technique to stop PPH and need for hysterectomy to stop the bleeding | Intra-operative and up to 24 hours postpartum | |
Primary | Incidence of complications | short term (intraoperative and up to 6 weeks postpartum)-long term:up to 2 years postpartum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04518163 -
Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa
|
N/A | |
Recruiting |
NCT04518150 -
Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section
|
N/A | |
Recruiting |
NCT03638024 -
Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
|
||
Terminated |
NCT01996345 -
Vaginal Pessary Versus Expectant Management for Placenta Previa
|
N/A | |
Recruiting |
NCT04609527 -
Management of Placenta Accreta Spectrum
|
Phase 2/Phase 3 | |
Completed |
NCT03431116 -
Low Implanted Second Trimester Placenta and Placenta Previa
|
N/A | |
Completed |
NCT03321435 -
The Placenta Previa and Fetal Weight
|
N/A | |
Enrolling by invitation |
NCT05529381 -
Anxiety and Depressive Symptoms in Placenta Previa / Accreta
|
||
Completed |
NCT04264234 -
Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria
|
N/A | |
Completed |
NCT05340205 -
Blood Loss During Cesarean Delivery in Placenta Previa Patients
|
Phase 4 | |
Completed |
NCT03570723 -
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
|
N/A | |
Completed |
NCT05283122 -
Mostafa Maged Technique to Control and Prevent the Post-Partum Bleeding From the Lower Uterine Segment in Placenta Previa Cases
|
N/A | |
Withdrawn |
NCT01442207 -
Cerclage for Prevention on Preterm Birth in Women With Placenta Previa
|
Phase 3 | |
Not yet recruiting |
NCT03451136 -
Cervical Length in Cases of Placenta Previa
|
N/A | |
Completed |
NCT02966197 -
Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
|
N/A | |
Recruiting |
NCT05802251 -
Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
|
||
Completed |
NCT03542552 -
Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa
|
Phase 3 | |
Recruiting |
NCT03124472 -
Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa
|
N/A | |
Recruiting |
NCT03633175 -
Progesterone in Patients With Placenta Previa
|
Phase 2 | |
Not yet recruiting |
NCT03208842 -
Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar
|
N/A |